Cabergoline may act as a radioprotective agent in Cushing's disease
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Endocrinology"
DOI: 10.1111/cen.14123
Abstract: Conventional fractionated radiotherapy (CRT) achieves control of pathological hypercortisolism in 75%‐80% of patients with persistent or recurrent Cushing's disease (CD), over a mean period of 18‐24 months. Medical therapy is recommended as bridge therapy while… read more here.
Keywords: cushing disease; act radioprotective; agent cushing; radioprotective agent ... See more keywords